International Journal of Retina and Vitreous

Scope & Guideline

Exploring breakthroughs in retina and vitreous science.

Introduction

Welcome to your portal for understanding International Journal of Retina and Vitreous, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationINT J RETINA VITR / Int. J. Retina Vitr.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The International Journal of Retina and Vitreous focuses on advancing the understanding of retinal and vitreous diseases through innovative research and clinical practices. The journal aims to provide a platform for the dissemination of significant findings in the field, encompassing a wide range of topics related to ocular health, surgical techniques, and emerging technologies.
  1. Research on Retinal Diseases:
    The journal consistently publishes studies on various retinal conditions, including age-related macular degeneration, diabetic retinopathy, and retinal detachment, emphasizing both clinical and experimental research.
  2. Innovative Surgical Techniques:
    A core focus of the journal is the exploration of new surgical methods and technologies in vitreoretinal surgery, including vitrectomy techniques and the use of advanced imaging modalities.
  3. Artificial Intelligence Applications:
    The journal highlights the integration of artificial intelligence and machine learning in ophthalmology, particularly in diagnostics and treatment planning for retinal diseases.
  4. Systematic Reviews and Meta-Analyses:
    Regular publications feature systematic reviews and meta-analyses that synthesize existing research, providing comprehensive insights and evidence-based recommendations for clinical practice.
  5. Clinical Outcomes and Long-Term Follow-Up Studies:
    Research assessing the long-term outcomes of various treatment modalities and interventions for retinal conditions is a key area of focus, contributing to improved patient management.
The International Journal of Retina and Vitreous reflects dynamic trends in the field of retinal research, with several emerging themes gaining traction. These trends highlight the journal's responsiveness to current advancements and the evolving landscape of ophthalmology.
  1. Artificial Intelligence and Machine Learning:
    There is a marked increase in research exploring the applications of AI and machine learning in diagnosing and managing retinal diseases, indicating a trend towards leveraging technology for enhanced patient care.
  2. Advanced Imaging Techniques:
    The journal is witnessing a surge in studies utilizing novel imaging technologies, such as optical coherence tomography (OCT) and OCT angiography, to provide deeper insights into retinal conditions and treatment efficacy.
  3. Personalized and Precision Medicine:
    Emerging themes of personalized treatment approaches and precision medicine in managing retinal diseases are becoming more prevalent, reflecting a shift towards tailoring therapies based on individual patient characteristics.
  4. Combination Therapies:
    Research focusing on combination therapies, particularly in the treatment of complex conditions like diabetic macular edema and neovascular age-related macular degeneration, is trending as clinicians seek to enhance treatment outcomes.
  5. Telemedicine and Remote Monitoring:
    The rise of telemedicine and remote monitoring tools for retinal disease management is increasingly featured, emphasizing the need for accessible care solutions in the current healthcare landscape.

Declining or Waning

While the journal has a robust focus on numerous emerging areas, certain themes appear to be declining in prominence over recent years. These waning scopes indicate shifts in research priorities or diminishing interest in specific topics.
  1. Traditional Pharmacological Treatments:
    Research centered on conventional pharmacological treatments for retinal diseases, such as corticosteroids and older anti-VEGF therapies, has decreased as newer agents and combination therapies gain attention.
  2. Basic Science and Animal Studies:
    There is a noticeable decline in purely basic science research and animal studies, as the journal increasingly prioritizes clinical applications and translational research that directly impacts patient care.
  3. Epidemiological Studies:
    The frequency of epidemiological studies related to retinal conditions appears to be waning, likely due to a growing emphasis on clinical trials and therapeutic interventions.
  4. Historical Perspectives:
    Papers focusing on historical reviews or perspectives of retinal surgery and treatment practices are less common, as the journal shifts towards contemporary issues and future directions in the field.
  5. Surgical Complications Reporting:
    While surgical outcomes remain a critical area, the specific reporting on complications and their management has seen a reduction, possibly due to a focus on positive outcomes and advancements in techniques.

Similar Journals

ACTA OPHTHALMOLOGICA

Bridging Research and Clinical Practice in Ophthalmology
Publisher: WILEYISSN: 1755-375XFrequency: 8 issues/year

ACTA OPHTHALMOLOGICA, published by Wiley, is a premier academic journal dedicated to advancing the field of ophthalmology and related medical disciplines. Established in 1923 and maintaining esteemed status through converged years until 1994, and then from 2008 to the present, this journal has consistently delivered pioneering research, reviews, and clinical advancements essential for both practitioners and researchers in eye care. With an impressive impact factor and ranking within the top 15 of its category, ACTA OPHTHALMOLOGICA stands as a Q1 journal in both Medicine (Miscellaneous) and Ophthalmology, reflecting its significant contribution to the field. Although it is not an open-access journal, it continues to offer valuable insights and empirical findings that inform clinical practices and innovative research approaches. As such, it remains a vital resource for scholars, clinicians, and students keen to stay at the forefront of ophthalmological science.

International Journal of Ophthalmology

Advancing Vision Through Innovative Research
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

OPHTHALMOLOGICA

Pioneering Research at the Intersection of Vision and Science
Publisher: KARGERISSN: 0030-3755Frequency: 6 issues/year

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

Illuminating the path of ocular research since 1945.
Publisher: CONSEL BRASIL OFTALMOLOGIAISSN: 0004-2749Frequency: 6 issues/year

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Pioneering Insights into Ocular Diseases
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

EXPERIMENTAL EYE RESEARCH

Exploring the Frontiers of Visual Mechanisms
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0014-4835Frequency: 12 issues/year

EXPERIMENTAL EYE RESEARCH, published by Academic Press Ltd - Elsevier Science Ltd, is a preeminent journal dedicated to advancing the fields of ophthalmology and neuroscience. With a history of insightful publications dating back to 1961, this journal serves as a critical platform for researchers, professionals, and students interested in the cellular and molecular mechanisms underlying visual processes. The journal boasts impressive rankings, including being placed in the top quartile (Q1) of both the Ophthalmology and Sensory Systems categories, and is recognized in the 2nd quartile (Q2) for Cellular and Molecular Neuroscience. With an impact factor reflecting its significant contribution to the field, EXPERIMENTAL EYE RESEARCH is a valuable resource that promotes the exchange of innovative research and ideas essential for understanding the complexities of eye function and vision-related disorders. Researchers looking to publish their findings or stay abreast of the latest studies will find this journal a vital component of their academic toolkit.

Ophthalmology Retina

Bridging research and practice in retinal care.
Publisher: ELSEVIER INCISSN: 2468-6530Frequency: 12 issues/year

Ophthalmology Retina is a premier academic journal dedicated to advancing the field of retinal research and clinical practice. Published by Elsevier Inc, this esteemed journal is instrumental for professionals and researchers focusing on the rapidly evolving domain of ophthalmology. Being ranked in the Q1 category for Ophthalmology and achieving an impressive ranking of 12 out of 137 in Scopus, it holds a significant place in the academic community, underscoring its quality and impact with a remarkable 91st percentile ranking. Covering an extensive range of topics from basic science to innovative clinical applications, the journal aims to bridge the gap between research and practice, offering invaluable insights to enhance patient care. The journal is dedicated to publishing high-quality research and reviews, fostering a forum for discussion and collaboration among thought leaders in the field. With its commitment to excellence and relevance, Ophthalmology Retina is a vital resource for anyone seeking to stay at the forefront of retinal studies.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Advancing the Frontiers of Eye Care Research
Publisher: WILEYISSN: 1442-6404Frequency: 9 issues/year

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

SURVEY OF OPHTHALMOLOGY

Illuminating the Path of Ophthalmic Research
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

CURRENT EYE RESEARCH

Transforming Insights into Eye Care Solutions
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.